Skip to main content

Recurrent C. difficile Research Studies

Clostridium difficile, also known as Clostridioides difficile and often referred to as C. difficile or C. diff, is a bacterium that can cause symptoms ranging from diarrhea to life-threatening inflammation of the colon.

Investigators

4964-Fischer, Monika

Monika Fischer, MD

Associate Professor of Medicine

Read Bio

Open Research Studies for Recurrent C. difficile

IMT Database (U. Minnesota)

Enrolling: Yes

Principle Investigator: Monica Fischer, MD

Duration:  1 year

Patient Population:  Adult patients receiving  treatment for recurrent CDI

Study Intervention:   Oral IMT or colonic IMT – questionnaire follow up for 1 year.

Icon 2 (MERCK)

Enrolling: ON HOLD

Principle Investigator: Monica Fischer, MD

Duration: 26 weeks

Patient Population:  Adult patients with IBD and CDI undergoing an FMT as standard of care

Study Intervention:  Bezlotuxumab Infusion in conjunction with FMT

Possibility of Placebo:  50% of not receiving Bezlotuxumab